Form 4: InnovAge Chief Legal Officer Granted Significant Equity

InnovAge Holding Corp.'s Chief Legal Officer, Nicole D'Amato, was granted 125,598 Restricted Stock Units, increasing her beneficial ownership to 334,110 shares.

Summary

• Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp. (INNV), was granted 125,598 Restricted Stock Units (RSUs) on July 15, 2025.
• These RSUs were acquired at a price of $0, indicating a direct grant.
• The RSUs are structured to vest in three equal installments on the anniversary of the grant date.
• Vesting is contingent upon Ms. D'Amato's continued service with InnovAge.
• Following this transaction, Ms. D'Amato's total beneficial ownership of InnovAge common stock is 334,110 shares.

Sentiment

Score: 7

Explanation: The grant of equity to a key executive is generally a positive sign for retention and alignment of interests, indicating stability in leadership and a commitment to long-term performance. It's a standard compensation practice.

Positives

• The grant of Restricted Stock Units to a key executive like the Chief Legal Officer aligns management's interests with those of shareholders.
• The vesting schedule over three years incentivizes long-term retention of a senior executive.
• Equity compensation at a $0 price indicates a direct grant, often used for performance incentives or retention.

Negatives

• The issuance of new shares upon vesting of RSUs could lead to minor dilution for existing shareholders, though this is a standard practice for equity compensation.

Future Outlook

The Restricted Stock Units will vest in three equal installments on the anniversary of the grant date, subject to continued service, indicating a future commitment and retention strategy.

Industry Context

Equity grants to senior executives are a common practice across industries, including healthcare services, to align management incentives with shareholder value and to retain key talent. This specific grant to the Chief Legal Officer of InnovAge Holding Corp. is consistent with typical executive compensation structures in publicly traded companies.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as a form of executive compensation is a widely adopted practice across various industries, including healthcare services, aligning with compensation strategies seen in companies like Humana Inc. (HUM) or Centene Corporation (CNC) for their senior executives.
• The vesting schedule of three equal annual installments is a common structure designed to promote long-term retention and performance, comparable to similar RSU programs at peer companies.
• The $0 acquisition price for RSUs is standard for direct grants, differentiating them from stock options which typically have an exercise price.

Stakeholder Impact

• Shareholders: Potential minor dilution upon RSU vesting, but improved alignment of executive interests with shareholder value.
• Employees: May signal stability in leadership and a commitment to retaining key talent.

Next Steps

• The Restricted Stock Units will vest in three equal installments on the anniversary of the grant date, contingent on the Chief Legal Officer's continued service.

Key Dates

Keywords

InnovAge Holding Corp, INNV, SEC Form 4, Restricted Stock Units, RSU, equity compensation, executive compensation, insider transaction, Nicole D'Amato, Chief Legal Officer, beneficial ownership